Key result
VEGF-A/VEGFR-2 tyrosine autophosphorylation regulates endothelial proliferation and migration, highlighting key anti-angiogenic targets.
Answers are grounded in this paper and cite their sources.
Vascular endothelial growth factor (VEGF)-A plays a critical role in vascular development and angiogenesis through its binding and activation of VEGF receptor-2 (VEGFR-2). The binding of VEGF-A to VEGFR-2 causes receptor dimerization, kinase activation and autophosphorylation of specific tyrosine residues within the dimeric complex. Tyrosine(Y)951 in the kinase-insert domain, Y1054 and Y1059 in the kinase domain and Y1175 and Y1214 in the C-terminal tail have been shown to serve as autophosphorylation sites. Phosphorylated Y1175 creates a binding site for phospholipase Cgamma1 (PLC-gamma1) and Shb. Activation of PLC-gamma1 and Shb regulates VEGF-A-dependent cell proliferation and cell migration, respectively. Phosphorylated Y951 binds and mediates tyrosine phosphorylation of the T-cell-specific adaptor protein (TSAd), which is expressed in endothelial cells. Y951-mediated coupling of VEGFR-2 and TSAd is critical for VEGF-A-induced cell migration and actin reorganization, and for pathological angiogenesis. These phosphorylation sites may be useful targets for the development of anti-angiogenic therapies to treat atherosclerosis and cancer.
No takes yet. Share an insight, caveat, or question.
Matsumoto et al. (2006) conducted a review in Angiogenesis, atherosclerosis, and cancer. VEGF-A and VEGFR-2 signaling was evaluated. VEGF-A signaling via VEGFR-2 regulates endothelial cell proliferation and migration through specific tyrosine autophosphorylation sites, presenting potential targets for anti-angiogenic therapies.
Synapse has enriched 10 related papers. Consider them for comparative context: